CLXT - Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference

PR Newswire

ROSEVILLE, Minn. , July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr , Chief Executive Officer, and Bill Koschak , Chief Financial Officer, will present at the Canaccord Genuity 42 ^nd Annual Growth Conference taking place August 8-11, 2022 .

The presentation details are as follows:

Date: Thursday, August 11, 2022
Presentation Time: 1:00 p.m. ET
Webcast: https://wsw.com/webcast/canaccord76/clxt/2481993

A webcast of the presentation will be available for viewing and replay on the Investors section of Calyxt's website at www.calyxt.com .

Management is also available for 1:1 meetings during the conference. Conference attendees should reach out to the event organizers or investors@calyxt.com to schedule.

About Calyxt:

Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the Company's synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com .

PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.

Contacts:

SOURCE Calyxt, Inc.